Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
MTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Robbins Edward Hutchinson Jr.EVP, General Counsel |  TLSTELOS CORPOpen-market sale | SELL | $259K 64.5K sh | Mar 19, 2026 |
| 32 | Hurley Joseph LChief Supply Chain Officer |  SFMSprouts Farmers Market, Inc.Open-market sale | SELL | $38K 456 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Leggett ThomasChief Financial Officer |  STOKStoke Therapeutics, Inc.Open-market sale | SELL | $1,215 37 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer |  TARSTarsus Pharmaceuticals, Inc.Open-market sale | SELL | $26K 379 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Coffin KimSVP, Chief Forager | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $39K 467 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Zalatoris TimmiChief Human Resources Officer | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $49K 585 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 32 | Navratil TomasCHIEF DEVELOPMENT OFFICER |  GKOSGLAUKOS CorpOpen-market sale | SELL | $27K 272 sh | Mar 19, 2026 traded Mar 16, 2026 |
| 32 | Leggett ThomasChief Financial Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $5,468 172 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Hoitt JasonChief Patient Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $4,419 139 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Hoitt JasonChief Patient Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $986 30 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 29 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $711K 8,666 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 29 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $2,365 72 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 29 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $11K 334 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 28 | Reed Marcy L.Director |  CLHCLEAN HARBORS INCOpen-market sale | SELL | $241K 836 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 28 | Wills Phillip R. IIIDirector |  FVCBFVCBankcorp, Inc.Open-market sale | SELL | $170K 11.5K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 28 | Liegel Matthew AChief Accounting Officer |  TGTTARGET CORPOpen-market sale | SELL | $241K 2,053 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 28 | von Heynitz HaraldDirector |  FLNCFluence Energy, Inc.Open-market sale | SELL | $165K 10.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner |  DSPViant Technology Inc.Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 300 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $100K 8,760 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 23 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $180K 15.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Geller AdamChief Product Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $233K 1,485 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 22 | Woolsey Staci MChief Financial Officer |  GVAGRANITE CONSTRUCTION INCOpen-market sale · 10b5-1 plan | SELL | $183K 1,523 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 22 | Geller AdamChief Product Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $321K 2,094 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 21 | Tamari ShaharDirector, COO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $563K 16.7K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 21 | Larkin Kyle TDirector, President & CEO | GVAGRANITE CONSTRUCTION INC Open-market sale · 10b5-1 plan | SELL | $877K 7,314 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $117K 3,577 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $86K 2,587 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $191K 6,100 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Beer James ADirector | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 177 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 19 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $177K 15.0K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 18 | Kelly Patrick ArthurCo-President and COO |  CIFRCipher Digital Inc.Open-market sale · 10b5-1 plan | SELL | $533K 35.6K sh | Mar 19, 2026 traded Mar 16, 2026 |
| 16 | Baroni DarioPresident, IDL |  MCDMCDONALDS CORPOpen-market sale · 10b5-1 plan | SELL | $194K 600 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Peterson JustinChief Technology Officer |  TWTradeweb Markets Inc.Open-market sale · 10b5-1 plan | SELL | $401K 3,212 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Verjus Nathalie Claude OdileCompany Secretary |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $15K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |